CN103191437A - 一种葡萄糖响应性药物控释载体的制备方法 - Google Patents
一种葡萄糖响应性药物控释载体的制备方法 Download PDFInfo
- Publication number
- CN103191437A CN103191437A CN2013100688337A CN201310068833A CN103191437A CN 103191437 A CN103191437 A CN 103191437A CN 2013100688337 A CN2013100688337 A CN 2013100688337A CN 201310068833 A CN201310068833 A CN 201310068833A CN 103191437 A CN103191437 A CN 103191437A
- Authority
- CN
- China
- Prior art keywords
- solution
- con
- polymer
- glucose
- stir
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 title claims abstract description 44
- 239000008103 glucose Substances 0.000 title claims abstract description 44
- 239000003814 drug Substances 0.000 title claims abstract description 20
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- 238000013270 controlled release Methods 0.000 title claims abstract description 13
- 229940079593 drug Drugs 0.000 title abstract description 3
- AFOSIXZFDONLBT-UHFFFAOYSA-N divinyl sulfone Chemical compound C=CS(=O)(=O)C=C AFOSIXZFDONLBT-UHFFFAOYSA-N 0.000 claims abstract description 65
- 239000000243 solution Substances 0.000 claims abstract description 53
- 229920000642 polymer Polymers 0.000 claims abstract description 39
- 239000007853 buffer solution Substances 0.000 claims abstract description 26
- 238000006243 chemical reaction Methods 0.000 claims abstract description 25
- 230000003213 activating effect Effects 0.000 claims abstract description 23
- 239000000839 emulsion Substances 0.000 claims abstract description 21
- 239000000203 mixture Substances 0.000 claims abstract description 21
- 239000003381 stabilizer Substances 0.000 claims abstract description 20
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000011259 mixed solution Substances 0.000 claims abstract description 7
- 108010062580 Concanavalin A Proteins 0.000 claims description 77
- 238000003756 stirring Methods 0.000 claims description 60
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 claims description 40
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 22
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical group [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 22
- 229920001100 Polydextrose Polymers 0.000 claims description 20
- 238000004108 freeze drying Methods 0.000 claims description 20
- 239000001259 polydextrose Substances 0.000 claims description 20
- 229940035035 polydextrose Drugs 0.000 claims description 20
- 235000013856 polydextrose Nutrition 0.000 claims description 20
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 18
- 238000000605 extraction Methods 0.000 claims description 15
- 229920001503 Glucan Polymers 0.000 claims description 14
- 239000002253 acid Substances 0.000 claims description 14
- TWNIBLMWSKIRAT-VFUOTHLCSA-N levoglucosan Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@H]2CO[C@@H]1O2 TWNIBLMWSKIRAT-VFUOTHLCSA-N 0.000 claims description 14
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 13
- 239000008367 deionised water Substances 0.000 claims description 11
- 229910021641 deionized water Inorganic materials 0.000 claims description 11
- 230000001376 precipitating effect Effects 0.000 claims description 11
- 238000005406 washing Methods 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- PPSTVZDCGHLXFU-UHFFFAOYSA-N C(C=C)(=O)OCCC.[O] Chemical compound C(C=C)(=O)OCCC.[O] PPSTVZDCGHLXFU-UHFFFAOYSA-N 0.000 claims description 10
- YXIUAEGTVQBVFN-UHFFFAOYSA-N [O].CC=CCC Chemical group [O].CC=CCC YXIUAEGTVQBVFN-UHFFFAOYSA-N 0.000 claims description 10
- 150000002148 esters Chemical class 0.000 claims description 10
- 229920001917 Ficoll Polymers 0.000 claims description 9
- 229920002651 Polysorbate 85 Polymers 0.000 claims description 9
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 9
- 229940113171 polysorbate 85 Drugs 0.000 claims description 9
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 6
- 239000003513 alkali Substances 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 6
- 239000000872 buffer Substances 0.000 claims description 5
- 238000004090 dissolution Methods 0.000 claims description 4
- 239000008363 phosphate buffer Substances 0.000 claims description 4
- 239000007981 phosphate-citrate buffer Substances 0.000 claims description 4
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 claims description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 3
- 229910017604 nitric acid Inorganic materials 0.000 claims description 3
- 239000001117 sulphuric acid Substances 0.000 claims description 3
- 235000011149 sulphuric acid Nutrition 0.000 claims description 3
- 238000000502 dialysis Methods 0.000 claims description 2
- 238000000034 method Methods 0.000 abstract description 10
- 230000009286 beneficial effect Effects 0.000 abstract description 3
- 238000011031 large-scale manufacturing process Methods 0.000 abstract description 3
- 239000003446 ligand Substances 0.000 abstract description 2
- 238000000151 deposition Methods 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 229910019142 PO4 Inorganic materials 0.000 description 12
- 239000008366 buffered solution Substances 0.000 description 12
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 12
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 12
- 239000010452 phosphate Substances 0.000 description 12
- 238000006467 substitution reaction Methods 0.000 description 10
- 239000007864 aqueous solution Substances 0.000 description 9
- 235000011121 sodium hydroxide Nutrition 0.000 description 9
- 230000001105 regulatory effect Effects 0.000 description 8
- 102000004877 Insulin Human genes 0.000 description 6
- 108090001061 Insulin Proteins 0.000 description 6
- 229940125396 insulin Drugs 0.000 description 6
- HBOMLICNUCNMMY-KJFJCRTCSA-N 1-[(4s,5s)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione Chemical compound O=C1NC(=O)C(C)=CN1C1O[C@H](CO)[C@@H](N=[N+]=[N-])C1 HBOMLICNUCNMMY-KJFJCRTCSA-N 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 230000004048 modification Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 229920002307 Dextran Polymers 0.000 description 3
- -1 acrylyl oxy-ethyl Chemical group 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- GHCZTIFQWKKGSB-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;phosphoric acid Chemical compound OP(O)(O)=O.OC(=O)CC(O)(C(O)=O)CC(O)=O GHCZTIFQWKKGSB-UHFFFAOYSA-N 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 238000002390 rotary evaporation Methods 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 238000006845 Michael addition reaction Methods 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 108010047620 Phytohemagglutinins Proteins 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 210000004153 islets of langerhan Anatomy 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- DCUFMVPCXCSVNP-UHFFFAOYSA-N methacrylic anhydride Chemical compound CC(=C)C(=O)OC(=O)C(C)=C DCUFMVPCXCSVNP-UHFFFAOYSA-N 0.000 description 1
- 238000010534 nucleophilic substitution reaction Methods 0.000 description 1
- OSCBARYHPZZEIS-UHFFFAOYSA-N phenoxyboronic acid Chemical group OB(O)OC1=CC=CC=C1 OSCBARYHPZZEIS-UHFFFAOYSA-N 0.000 description 1
- 230000001885 phytohemagglutinin Effects 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310068833.7A CN103191437B (zh) | 2013-03-05 | 2013-03-05 | 一种葡萄糖响应性药物控释载体的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310068833.7A CN103191437B (zh) | 2013-03-05 | 2013-03-05 | 一种葡萄糖响应性药物控释载体的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103191437A true CN103191437A (zh) | 2013-07-10 |
CN103191437B CN103191437B (zh) | 2015-03-11 |
Family
ID=48714368
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310068833.7A Active CN103191437B (zh) | 2013-03-05 | 2013-03-05 | 一种葡萄糖响应性药物控释载体的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103191437B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105147639A (zh) * | 2015-09-02 | 2015-12-16 | 华东理工大学 | 一种葡萄糖/光双响应性核壳微球及其制备方法和应用 |
CN106937948A (zh) * | 2017-02-23 | 2017-07-11 | 青岛农业大学 | 葡萄糖响应型的伴刀豆球蛋白‑淀粉纳米颗粒的制备方法及其应用 |
CN110882231A (zh) * | 2018-08-17 | 2020-03-17 | 中国农业大学 | 葡萄糖响应的氧化淀粉微球及其制备方法和应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101745114A (zh) * | 2009-12-25 | 2010-06-23 | 浙江工业大学 | 一种对葡萄糖敏感可自控释胰岛素的生物材料的制备方法 |
-
2013
- 2013-03-05 CN CN201310068833.7A patent/CN103191437B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101745114A (zh) * | 2009-12-25 | 2010-06-23 | 浙江工业大学 | 一种对葡萄糖敏感可自控释胰岛素的生物材料的制备方法 |
Non-Patent Citations (2)
Title |
---|
YU YU: "《One-Step "Click" Method for Generating Vinyl Sulfone Groups on Hydroxyl-Containing Water-Soluble Polymers》", 《BIOMACROMOLECULES》 * |
张小华: "《基于伴刀豆球蛋白A的溶胶-凝胶互变糖敏感系统研究进展》", 《中国新药杂志》 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105147639A (zh) * | 2015-09-02 | 2015-12-16 | 华东理工大学 | 一种葡萄糖/光双响应性核壳微球及其制备方法和应用 |
CN105147639B (zh) * | 2015-09-02 | 2019-02-01 | 华东理工大学 | 一种葡萄糖/光双响应性核壳微球及其制备方法和应用 |
CN106937948A (zh) * | 2017-02-23 | 2017-07-11 | 青岛农业大学 | 葡萄糖响应型的伴刀豆球蛋白‑淀粉纳米颗粒的制备方法及其应用 |
CN106937948B (zh) * | 2017-02-23 | 2019-07-05 | 青岛农业大学 | 葡萄糖响应型的伴刀豆球蛋白-淀粉纳米颗粒的制备方法及其应用 |
CN110882231A (zh) * | 2018-08-17 | 2020-03-17 | 中国农业大学 | 葡萄糖响应的氧化淀粉微球及其制备方法和应用 |
CN110882231B (zh) * | 2018-08-17 | 2021-09-17 | 中国农业大学 | 葡萄糖响应的氧化淀粉微球及其制备方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
CN103191437B (zh) | 2015-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108434125B (zh) | 一种介孔二氧化硅-胰岛素纳米缓释经皮贴剂的制备方法 | |
EP2659883A1 (en) | Microcapsule preparation of alginate-chitosan acyl derivatives, preparation and application thereof | |
CN103191437B (zh) | 一种葡萄糖响应性药物控释载体的制备方法 | |
CN110180026B (zh) | 一种生物支架及其制备方法和应用 | |
CN103301788B (zh) | Peg接枝改性的海藻酸盐-壳聚糖微胶囊及制备和应用 | |
CN103028117A (zh) | 细菌纤维素凝胶复合材料的制备方法 | |
CN107375196A (zh) | 一种含儿茶酚基天然多糖复合水凝胶载体及其制备方法 | |
CN104306325A (zh) | 一种抗肿瘤水凝胶的制备方法 | |
CN103992452A (zh) | 一种具备糖、温度、pH三重敏感性的星型嵌段共聚物及其制备方法 | |
CN103126975B (zh) | 一种具有梯度药物浓度的水凝胶贴剂基质的制备方法 | |
CN103083712A (zh) | 掺入有干细胞或其它生物活性物质的外科敷料 | |
CN103480037A (zh) | 用于心衰辅助治疗的可注射型海藻酸基生物材料及其制备方法 | |
CN101066457A (zh) | 一种可注射型温敏性壳聚糖/甲基纤维素凝胶及其制备方法 | |
CN114601918A (zh) | 一种葡萄糖响应胰岛素微针贴片及其制备方法 | |
CN102391429A (zh) | 一种pH敏感的木聚糖水凝胶及其制备方法 | |
CN104365596B (zh) | 一种鞋用盐酸特比萘芬微胶囊抗菌剂的制备方法 | |
CN103191441B (zh) | 一种刺激响应型酯化纳米纤维素前药缓释材料的制备方法 | |
CN106065039B (zh) | 一种水溶性抗菌压克力高分子银盐的制备方法 | |
CN102659980B (zh) | 一种双亲水温敏聚合物纳米胶束的制备方法 | |
CN103992483A (zh) | 一种具有糖、温度和pH三重敏感性的药物输送材料及其制备方法 | |
CN103110956B (zh) | 一种葡萄糖响应性胰岛素自调节释放载体的制备方法 | |
CN100509923C (zh) | 一种温度敏感型的壳聚糖/聚乙烯醇凝胶及其制备方法 | |
Suzuki et al. | Cyotomedical therapy for insulinopenic diabetes using microencapsulated pancreatic β cell lines | |
CN103751149A (zh) | 一种负载水不溶性药物的γ-聚谷氨酸/明胶纳米粒及其制备方法 | |
AU2007295132A1 (en) | Method for producing insulin in the form of an oral preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20201125 Address after: No. 159, Chengjiang Middle Road, Jiangyin City, Wuxi City, Jiangsu Province Patentee after: Jiangyin Intellectual Property Operation Co.,Ltd. Address before: Gehu Lake Road Wujin District 213164 Jiangsu city of Changzhou province No. 1 Patentee before: CHANGZHOU University |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240604 Address after: 210000 10th floor, building 5, juhuiyuan, phase II, Xuzhuang high tech Zone, 108 Xuanwu Avenue, Xuanwu District, Nanjing City, Jiangsu Province Patentee after: Nanjing Tinuo Pharmaceutical Technology Co.,Ltd. Country or region after: China Address before: No. 159, Chengjiang Middle Road, Jiangyin City, Wuxi City, Jiangsu Province Patentee before: Jiangyin Intellectual Property Operation Co.,Ltd. Country or region before: China |